Ethylene oxide plant reopening won’t halt FDA plans to seek alternatives

The FDA will continue its efforts to find alternative medical device sterilization methods to ethylene oxide (EO), even though a major EO plant is slated to reopen.

Yesterday, medtech sterilization company Sterigenics and the state of Illinois announced they had reached a proposed consent agreement to reopen a plant in Willowbrook, Ill., which the state shut down in February, citing excessive emissions of EO, a carcinogenic gas. The plant had sterilized millions of devices annually — 594 types of devices, according to the FDA, including sutures, clamps, knives, stents and needles.

Get the full story on our sister site, Medical Design & Outsourcing.

Building Better Companies at DeviceTalks Minnesota DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as: Navigating the path to market Reimbursement Winning regulatory approval Corporate culture Entering global markets Leadership Join industry leaders and medical device professionals at the most awaited medtech conference of the year, DeviceTalks Minnesota. Use code SAVE15 to save 15%! REGISTER NOW